Biopharma Deal Strategy Outlook

The industry continues to face headwinds and so far 2024 has been slightly slower than 2023 and the prior two years.  Factors such as higher interest rates, the loss of patent exclusivity, political uncertainty, potential policy changes, and other dynamic market conditions are impacting deal-making and the pace of innovation. However, amidst these challenges, there are also emerging market trends and advancements in therapeutic approaches that present exciting opportunities.

As we approach 2025, this paper offers valuable insights into the trends, challenges, and opportunities that will shape the industry.